Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

HRSA 340B rebate pilot to include 21 drugs, 10 drugmakers

2 October 2026 · By · Wire by Fusion42

Published

2 October 2026

Topic

operational-macro

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at modernhealthcare.com →

◆ Verified

Fusion42 · 2 October 2026 · Fusion42 review

The Health Resources and Services Administration (HRSA) announced a pilot program to test replacing discounts with rebates under the 340B Drug Pricing Program, involving 21 drugs from 10 drugmakers.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

Your drug pricing model faces change as rebates replace discounts in a major pilot. Drugmakers and healthcare providers must adjust strategies now to maintain margins and compliance.

◆ Coverage

1 source · 2 Oct 2026

◆ Related on Wire

◆ Topics

Health340b-programdrugmakersrebate-pilothrsadrug-pricing